$358.07
0.20%
Nasdaq, Fri, Oct 02 2026.
ISIN
US07725L1026
Symbol
BGNE

BeiGene Ltd. Sponsored ADR Target price 2026 - Analyst rating & recommendation

BeiGene Ltd. Sponsored ADR Classifications & Recommendation

Buy
92%
Hold
8%

BeiGene Ltd. Sponsored ADR Price Target

Target Price $45.21
Price $358.07
Deviation
Number of Estimates 7
7 Analysts have issued a price target BeiGene Ltd. Sponsored ADR 2027 . The average BeiGene Ltd. Sponsored ADR target price is $45.21. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 11 Analysts recommend BeiGene Ltd. Sponsored ADR to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BeiGene Ltd. Sponsored ADR stock has an average upside potential 2027 of . Most analysts recommend the BeiGene Ltd. Sponsored ADR stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 5.70 7.02
40.46% 23.06%
EBITDA Margin 9.23% 18.34%
168.74% 98.60%
Net Margin 3.82% 12.88%
120.89% 237.05%

7 Analysts have issued a sales forecast BeiGene Ltd. Sponsored ADR 2026 . The average BeiGene Ltd. Sponsored ADR sales estimate is

$7.0b
unlock
. This is
9.58% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$7.5b 17.44%
unlock
, the lowest is
$6.6b 3.74%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $5.7b 40.46%
2026
$7.0b 23.06%
unlock
2027
$8.1b 15.48%
unlock
2028
$9.1b 12.48%
unlock
2029
$9.3b 1.96%
unlock
2030
$10.3b 11.22%
unlock
2031
$11.2b 8.61%
unlock
2032
$12.3b 9.45%
unlock
2033
$13.3b 8.56%
unlock

7 BeiGene Ltd. Sponsored ADR Analysts have issued a net profit forecast 2026. The average BeiGene Ltd. Sponsored ADR net profit estimate is

$904m
unlock
. This is
41.56% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.1b 65.46%
unlock
, the lowest is
$732m 14.68%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $218m 129.34%
2026
$904m 314.93%
unlock
2027
$1.3b 42.73%
unlock
2028
$1.7b 29.78%
unlock
2029
$22.5b 1,243.91%
unlock
2030
$28.1b 24.65%
unlock
2031
$27.9b 0.46%
unlock
2032
$39.2b 40.42%
unlock
2033
$45.2b 15.36%
unlock

Net Margin

2025 3.82% 120.89%
2026
12.88% 237.05%
unlock
2027
15.93% 23.68%
unlock
2028
18.38% 15.38%
unlock
2029
242.22% 1,217.85%
unlock
2030
271.47% 12.08%
unlock
2031
248.80% 8.35%
unlock
2032
319.20% 28.30%
unlock
2033
339.20% 6.27%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 2.08 8.76
126.91% 321.15%
P/E 40.90
EV/Sales 5.44

7 Analysts have issued a BeiGene Ltd. Sponsored ADR forecast for earnings per share. The average BeiGene Ltd. Sponsored ADR EPS is

$8.76
unlock
. This is
47.47% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$10.23 72.22%
unlock
, the lowest is
$7.09 19.36%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $2.08 126.91%
2026
$8.76 321.15%
unlock
2027
$12.50 42.69%
unlock
2028
$16.22 29.76%
unlock
2029
$217.96 1,243.77%
unlock
2030
$271.68 24.65%
unlock
2031
$270.43 0.46%
unlock
2032
$379.75 40.42%
unlock
2033
$438.09 15.36%
unlock

P/E ratio

Current 60.28 102.77%
2026
40.90 32.15%
unlock
2027
28.65 29.95%
unlock
2028
22.08 22.93%
unlock
2029
1.64 92.57%
unlock
2030
1.32 19.51%
unlock
2031
1.32 0.00%
unlock
2032
0.94 28.79%
unlock
2033
0.82 12.77%
unlock

Based on analysts' sales estimates for 2026, the BeiGene Ltd. Sponsored ADR stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.97 32.00%
2026
5.44 8.80%
unlock
2027
4.72 13.40%
unlock
2028
4.19 11.09%
unlock
2029
4.11 1.92%
unlock
2030
3.70 10.08%
unlock
2031
3.40 7.93%
unlock
2032
3.11 8.64%
unlock
2033
2.86 7.89%
unlock

P/S ratio

Current 6.61 27.23%
2026
6.04 8.74%
unlock
2027
5.23 13.40%
unlock
2028
4.65 11.10%
unlock
2029
4.56 1.92%
unlock
2030
4.10 10.09%
unlock
2031
3.77 7.93%
unlock
2032
3.45 8.64%
unlock
2033
3.18 7.89%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today